Talk:Acute myeloid leukemia, IDH-mutated

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

Updated ivosidenib ref (full article published). Added enasidenib for 1st line nonfit (no FDA approval, but widely used). Both drugs often used in combination with aza/decitabine, add ena+aza nonfit based on DiNardo et al ASH 2019 abstr 643? --Kporkka (talk) 23:07, 8 January 2020 (EST)